Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation

Blood Cancer J. 2018 Jun 5;8(6):51. doi: 10.1038/s41408-018-0088-1.

Gregorio Barilà^{1

2}, Antonella Teramo^{1

2}, Giulia Calabretto^{1

2}, Chiara Ercolin^{1

2}, Elisa Boscaro¹, Valentina Trimarco^{1

2}, Samuela Carraro¹, Matteo Leoncin^{1

2}, Cristina Vicenzetto^{1

2}, Anna Cabrelle², Monica Facco^{1

2}, Francesco Piazza^{1

2}, Gianpietro Semenzato^{3

4}, Renato Zambello^{5

6}

¹ Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
² Venetian Institute of Molecular Medicine (VIMM), Padua, Italy.
³ Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy. [email protected].
⁴ Venetian Institute of Molecular Medicine (VIMM), Padua, Italy. [email protected].
⁵ Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy. [email protected].
⁶ Venetian Institute of Molecular Medicine (VIMM), Padua, Italy. [email protected].

No abstract available

Publication types